What is CheckEye?
А cloud-based solution to detect diabetic retinopathy using photographic images of eye fundus through the ML\AI algorithm.
According to the International Diabetes Federation, over 537 million people are living with diabetes globally and this number is growing at an alarming rate. Most of these people will develop some form of retinopathy causing reduced vision or, in severe cases, blindness.
‘Everyone with diabetes is at risk of losing vision.’
– International Diabetes Federation
The World Health Organisation defines diabetic retinopathy as the leading cause of blindness in the working age population in most countries. However, early diagnosis and timely treatment of diabetic retinopathy can prevent sight impairment and blindness. Interventions that are both cost-saving and feasible include screening and treatment for retinopathy.
approximately 2% of people become blind,
and about 10% develop severe visual impairment.’
– World Health Organisation
CheckEye has developed a cloud-based solution to detect diabetic retinopathy using photographic images of eye fundus through the ML\AI algorithm. Photographs can be taken anywhere – from optic retailers to pharmacies – by non-medical staff to be further uploaded to the system for diagnosis. CheckEye will make early detection of diabetic retinopathy and retinopathy prevention easily accessible for all.
The public health and economic benefits of early detection, prevention and treatment of diabetic retinopathy are immense.
REDUCED WAITING TIME
Reduced waiting time to access professional treatment by receiving quick and accurate retinopathy screening test results in a wide network of locations.
BETTER COST EFFICIENCY
More cost effective treatment of diabetic retinopathy
Early detection and timely treatment of diabetic retinopathy in people living with diabetes.
BETTER VISION FOR LIFE
Mitigated risk of developing a severe case of retinopathy and blindness.
EYE HEALTH PROFESSIONALS
MORE QUALITY TIME WITH PATIENTS
Increased efficiency of a specialist’s performance through freeing up time with Mobile Diabetic Retinopathy Screening which is otherwise invested in conducting routine screenings.
More accurate diagnosis through better quality of screening images achieved with AI-based technology
BETTER PERFORMANCE RESULTS
Higher rate of appointments for patients with screen-positive results who require treatment more urgently.
PUBLIC HEALTH SYSTEMS & INSURANCE COMPANIES
BETTER ACCESS TO SCREENING
Lowering the barriers for access and the cost of systematic Diabetic Eye Screening Test reduces disease burden on the public health and social care systems.
LESS FINANCIAL BURDEN
Early Detection of Diabetic Retinopathy brings down the cost of treatment timefold.
MORE ACCURATE SCREENING RESULTS
Automated image analysis systems provide a more accurate diagnosis compared to the manual grading, thus allowing to prioritise patients for treatment based on the severity of their condition.
CheckEye operates an international team based in the UK, Ukraine and Switzerland. Our shared credentials include decades of senior level experience across IT, telecom and health industries in global brands, higher education in the world’s best universities, and a profound understanding of the rapidly evolving healthcare trends globally.
Kirill is a senior IT professional with two decades of technology and IT product development experience. His role at CheckEye encompasses both general management and product development, underpinned by expertise gained across Kirill’s work in large corporates in information technology & security and business continuity roles across industries – energy, system integration and telecom. Kirill has been on the senior leadership teams in Ukraine’s largest names such as VEON, DTEK, and currently Ukrtelecom.
Kirill is a candidate for Global Executive MBA from IESE Business School, University of Navarra.
Dmitry is the head of the Artificial Intelligence Research and Development Center. He has over 10 years of experience in analyzing business needs and developing digital solutions. Prior to this, he worked in the field of finance and banking. He holds two higher education degrees. He is the founder and Chairman of the Supervisory Board of the Vinnytsia IT Association. He is also the founder of the UME ecosystem for learning and work. He is the author of the Country’s Digital Transformation concept.
Andrii is a Doctor of Medical Sciences, Senior Researcher, Head of the Department of Studying the Biological Action and Application of Lasers in Ophthalmology of the “The Filatov Institute of Eye Diseases and Tissue Therapy of the National Academy of Medical Sciences of Ukraine”, specialisation in ophthalmology: diagnosis of fundus diseases, laser microsurgery, treatment of fundus diseases using antiangiogenic factors. Author of 39 scientific articles in international journals included in the Scopus scientometric database, two monographs, scientific supervisor of three dissertations.
Member of the Ukrainian Society of Ophthalmologists, European Society of Retina Specialists – EURETINA, International Expert Group of Vision Academy.
Michael Shuranov, Communications Advisor
Michael is a senior communications professional bringing over 20 years of hands-on experience in public relations and reputation management. Having worked in senior communications roles in large corporates across food, retail and telecom including McDonald’s, Avon, VEON and currently Ukrtelecom, the largest telco in Ukraine, Michael advises CheckEye on the high level strategic positioning and comm steam design.
Michael teaches Media Relations at the Chartered Institute of Public Relations, Ukraine.
Head of Communications
Daria is a London-based strategic communications advisor and reputation management expert with over 15 years of experience. Daria’s career includes working in communication roles in/with complex matrix cross-border organisations such as BT, VEON, United Nations, and CNN International. With over 15 years of experience in international communications, she is responsible for developing the brand vision, core positioning and global communications strategies for CheckEye.
Daria graduated with an MA in Digital Culture and Society from King’s College London. She holds a CIPR Professional PR Diploma from London’s PR Academy and a Certificate in Analyst Relations from Forrester.
Andrew Chapkov is a lawyer and a project manager with 10+ years of experience in financial law and 8 successful projects in the financial, agricultural and medical sectors. Over the recent years, he has been focused on launching projects from scratch and overlooking their development to breakeven point and subsequent sale as ready-made business. Over the course of his career, Andrew managed teams of up to 1400 people.
At the recent conference on "Metabolic Disorders in the Focus of Preventive Medical Care" held in Uzhhorod, the CheckEye team, in collaboration with partners from the V.P. Filatov Institute, discussed the topic of prevention and diagnosis of metabolic diseases in the...
Artificial Intelligence, or AI, has long transcended the realm of science fiction and become an integral part of our everyday lives. We are familiar with its roles in areas such as autonomous cars and voice assistants, but there are numerous lesser-known facts about...
On September 14th, CheckEye and the Ukrainian Diabetic Federation signed a memorandum of cooperation with Lviv City Council."This will be done with the involvement of artificial intelligence, which has already become a part of our lives. In just 30 seconds, artificial...
A revolutionary therapy that has significantly improved the effectiveness of treating diabetic retinopathy is known as Anti-VEGF therapy. It is based on combating the growth factor called VEGF protein, which triggers the development of abnormal retinal blood vessels....
The connection between type 2 diabetes and smoking has been established through numerous studies. As far back as 2013, Chinese researchers found that smoking one pack of cigarettes per day increases the risk of diabetes by 25%. The key factor is visceral obesity, also...
A memorandum regarding the implementation of a program for diagnosing eye diseases in diabetic patients using the CheckEye technology with the use of artificial intelligence (AI) has been signed in Vinnytsia. Representatives of CheckEye, the Department of Health and...
Eli Lilly and Company's recently approved rapid-acting insulin, Lyumjev, has been generating significant attention since its FDA approval in March 2022. This new treatment option for individuals with type 1 and type 2 diabetes has been lauded for its quick onset of...
In Zakarpattia, the artificial intelligence CheckEye© will detect people with signs of diabetic retinopathy.
The medical startup CheckEye© is implementing diabetic retinopathy screening in the Zakarpattia region using artificial intelligence. It will assist endocrinologists and family doctors in detecting diabetic retinopathy at early stages. Through the collaboration...
On April 13, Kyrylo Goncharuk, CEO CheckEye, met with Professor Oleksandr Tolstanov, MD, president of the Association of Family Medicine of Ukraine, to discuss the future of CheckEye's initiative. Given the limited healthcare resources in Ukraine and the...
We are proud to announce that we have been accepted into the prestigious Impact Business Accelerator program. The program has recognized CheckEye as one of the 25 Ukrainian businesses and enterprises that are committed to integrating social impact as a core strategy....